Figure 2
Figure 2. Overall, event-free, and transformation-free survival for all patients receiving imatinib dose escalation after imatinib failure.

Overall, event-free, and transformation-free survival for all patients receiving imatinib dose escalation after imatinib failure.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal